Botulinum toxin type B
Indicated for: spasticity; dystonias; neuromuscular disorders
Search for medicines for human use
Index of medicine substances
Letter B · page 4
-
-
Bovine bile + sodium salicylate + methenamine
Indicated for: hepatobiliary disorders
A05AAN1 Alimentary tract and metabolism | Bile therapy | Bile acids and derivatives
-
Brentuximab vedotin
Indicated for: lymphoma
-
Brexpiprazol
Indicated for: schizophrenia; bipolar disorder
N05AX16 Nervous system | Antipsychotics | Other antipsychotics
-
Brexucabtagen autoleucel
Indicated for: hematologic malignancies
-
Brigatinib
Indicated for: non-small cell lung cancer
-
Brimonidine
Indicated for: glaucoma; ocular hypertension
-
Brimonidine + timolol
Indicated for: glaucoma; ocular hypertension
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
-
Brinzolamide
Indicated for: glaucoma; ocular hypertension
S01EC04 Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors
-
Brinzolamide + brimonidine
Indicated for: glaucoma; ocular hypertension
S01EC54 Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors
-
Brinzolamide + timolol
Indicated for: glaucoma; ocular hypertension
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
-
Brivaracetam
Indicated for: epilepsy
N03AX23 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
-
Brivudine
Indicated for: herpes zoster
-
Brolucizumab
Indicated for: macular degeneration; diabetic macular edema
S01LA06 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
-
Bromazepam
Indicated for: anxiety
N05BA08 Nervous system | Anxiolytics | Benzodiazepine derivatives
-
Bromelain proteolytic enzyme concentrate
Indicated for: wound debridement
-
Bromfenac
Indicated for: ocular inflammation
S01BC11 Sensory organs | Antiinflammatory agents | Antiinflammatory agents, non-steroids
-
Bromhexine
Indicated for: respiratory disorders with viscous secretions
R05CB02 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
-
Bromocriptine
Indicated for: Parkinson's disease; hyperprolactinemia
N04BC01 Nervous system | Dopaminergic agents | Dopamine agonists
-
Budesonide
Indicated for: asthma; inflammatory bowel disease
-
Budesonide + formoterol
Indicated for: asthma; chronic obstructive pulmonary disease
-
Bufexamac + bismuth subgallate + titanium dioxide + lidocaine
Indicated for: hemorrhoids; anorectal inflammation and pain
-
Buformin
Indicated for: type 2 diabetes mellitus
A10BA03 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Biguanides
-
Bulevirtide
Indicated for: chronic hepatitis D
J05AX28 Antiinfectives for systemic use | Direct acting antivirals | Other antivirals
-
Bupivacaine
Indicated for: local anesthesia
N01BB01 Nervous system | Anesthetics | Anesthetics, local | Amides
-
Buprenorphine
Indicated for: severe pain; opioid dependence
N07BC01 Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence
-
Buprenorphine + naloxone
Indicated for: opioid dependence; withdrawal
N07BC51 Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence
-
Bupropion
Indicated for: depression; smoking cessation
N06AX12 Nervous system | Antidepressants | Other antidepressants
-
Burosumab
Indicated for: X-linked hypophosphatemia
-
Buspirone
Indicated for: anxiety
N05BE01 Nervous system | Anxiolytics | Azaspirodecanedione derivatives